BIOMAT Database Logo BIOMAT Database Logo

Quinazolinones as γ-secretase modulators. 2011

Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Merck Research Laboratories Boston, 33 Avenue Louis Pasteur, Boston, MA 02115, USA. christian_fischer@merck.com

Synthesis, SAR and evaluation of styrenyl quinazolinones as novel gamma secretase modulators are presented in this communication. Starting from literature and in-house leads we evaluated a range of quinazolinones which showed good modulation of γ-secretase activity.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D052999 Quinazolinones Chemicals with two conjoined aromatic rings incorporating two nitrogen atoms and one of the carbons oxidized with a keto oxygen. Quinazolinedione,Quinazolinone,Quinazolinediones

Related Publications

Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Steroids as γ-secretase modulators.
September 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Aminothiazoles as γ-secretase modulators.
November 2011, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Pyridine-derived γ-secretase modulators.
August 2011, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
γ-Secretase inhibitors and modulators.
December 2013, Biochimica et biophysica acta,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Pyridazine-derived γ-secretase modulators.
July 2011, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.
May 2020, Alzheimer's research & therapy,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.
February 2011, Journal of medicinal chemistry,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.
January 2011, Bioorganic & medicinal chemistry letters,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
Suspected limited efficacy of γ-secretase modulators.
April 2013, Neurobiology of aging,
Christian Fischer, and Sanjiv Shah, and Bethany L Hughes, and George N Nikov, and Jamie L Crispino, and Richard E Middleton, and Alexander A Szewczak, and Benito Munoz, and Mark S Shearman
γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processing.
February 2022, Journal of cellular and molecular medicine,
Copied contents to your clipboard!